法莫斯利医药(PCYC)

淡投2014-12-04 07:16

$Pharmacyclics(PCYC)$ 生物分子论坛药化专版项目讨论（第一期）ＢＴＫ 抑制剂
网页链接查看全文

MT美股笔记2014-09-11 16:10

生化股今日走势强势 明天继续关注该板块 $阿里拉姆制药(ALNY)$ $Pharmacyclics(PCYC)$ $爱克莱恩(ACHN)$ 几只图形都不错 keep eyes on them!查看全文

madliu2014-07-15 10:40

$Pharmacyclics(PCYC)$ 17、依鲁替尼/ Imbruvica/Ibrutinib
商品名：Imbruvica
通用名：Ibrutinib
别名: PCI-32765,CRA-032765
中文名：依鲁替尼
适应症：套细胞淋巴瘤。
作用机理：不可逆布鲁顿酪氨酸激酶(BTK)抑制剂,与Btk活性位点半胱氨酸残基（Cys-481）选择性地共价结合,从...查看全文

garethsun2014-06-09 22:17

$Pharmacyclics(PCYC)$ 周五加了点仓，表现还不错查看全文

garethsun2014-06-06 22:25

$Pharmacyclics(PCYC)$貌似可以捞一把查看全文

从不放弃machine2014-02-25 22:05

$Pharmacyclics(PCYC)$ 年初最早105的时候买入。120的时候又卖了。没想到现在已经150了。。。查看全文

淡投2014-02-13 02:09

FDA approves $Pharmacyclics(PCYC)$ ibrutinib for chronic lymphocytic leukemia (CLL)查看全文

$Pharmacyclics(PCYC)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2015-05-26 AccNo: 0001104659-15-040557 Size: 80 KB 网页链接

$Pharmacyclics(PCYC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2015-06-10 AccNo: 0000080255-15-000597 Size: 24 KB 网页链接

$Pharmacyclics(PCYC)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2015-06-01 AccNo: 0000921895-15-001510 Size: 53 KB 网页链接

$Pharmacyclics(PCYC)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-05-26 AccNo: 0001193125-15-199336 Size: 38 KB 网页链接

$Pharmacyclics(PCYC)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-05-26 AccNo: 0001193125-15-199335 Size: 38 KB 网页链接

$Pharmacyclics(PCYC)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-05-26 AccNo: 0001193125-15-199334 Size: 38 KB 网页链接

$Pharmacyclics(PCYC)$ CT ORDER - Confidential treatment order Filed: 2015-06-15 AccNo: 9999999997-15-010863 Size: 10 KB 网页链接

$Pharmacyclics(PCYC)$ 8-K - Current report Filed: 2015-05-26 AccNo: 0001104659-15-040558 Size: 109 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem...

$Pharmacyclics(PCYC)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redee Filed: 2015-05-26 AccNo: 0001354457-15-000099 Size: 2 KB 网页链接

$Pharmacyclics(PCYC)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2015-06-05 AccNo: 0001104659-15-043562 Size: 25 KB 网页链接